Dr. Declan Doogan, MD
Chief Medical Officer, Juvenescence
We have around 11 years of un-health, or disability, at the end of life. Aging is a disease and we want to investigate the fundamental mechanisms of shortened longevity and look for solutions.
Dr. Declan Doogan, MD, co-founder of Juvenescence, was driven to start the company because he believes we all can do better in managing health as we get older.
Dr. Doogan, the Chief Medical Officer of Juvenescence, has more than 30 years experience in the global pharmaceutical industry. He was Head of Worldwide Drug Development at Pfizer, working in the US, UK and Japan. Dr. Doogan was also head of R&D at Amarin where he helped raise $100m to fund the reorganization and portfolio realignment leading to the NDA approval for Vascepa (icosapent ethyl) for elevated triglycerides.
During his career, Declan has engaged in activities to promote excellence in pharmaceutical medicine and sits on the boards of several biotechnology companies and multiple pharmaceutical companies. He is Chairman and co-founder of Biohaven Pharmaceuticals, Portage Biotech, and PHPrecisionmed.
Dr. Doogan graduated Medicine from Glasgow University, is a Fellow of the Royal College of Physicians and Surgeons of Glasgow, and holds an honorary degree of DSc from the University of Kent in the UK. He is visiting professor at Glasgow University.
Dr. Doogan practices what he preaches; staying healthy by vigorous exercise, dietary modification, nutritional supplementation and by having a rich social and family life.